Literature DB >> 11283678

Complement facilitates early prion pathogenesis.

M A Klein1, P S Kaeser, P Schwarz, H Weyd, I Xenarios, R M Zinkernagel, M C Carroll, J S Verbeek, M Botto, M J Walport, H Molina, U Kalinke, H Acha-Orbea, A Aguzzi.   

Abstract

New-variant Creutzfeldt-Jakob disease and scrapie are typically initiated by extracerebral exposure to the causative agent, and exhibit early prion replication in lymphoid organs. In mouse scrapie, depletion of B-lymphocytes prevents neuropathogenesis after intraperitoneal inoculation, probably due to impaired lymphotoxin-dependent maturation of follicular dendritic cells (FDCs), which are a major extracerebral prion reservoir. FDCs trap immune complexes with Fc-gamma receptors and C3d/C4b-opsonized antigens with CD21/CD35 complement receptors. We examined whether these mechanisms participate in peripheral prion pathogenesis. Depletion of circulating immunoglobulins or of individual Fc-gamma receptors had no effect on scrapie pathogenesis if B-cell maturation was unaffected. However, mice deficient in C3, C1q, Bf/C2, combinations thereof or complement receptors were partially or fully protected against spongiform encephalopathy upon intraperitoneal exposure to limiting amounts of prions. Splenic accumulation of prion infectivity and PrPSc was delayed, indicating that activation of specific complement components is involved in the initial trapping of prions in lymphoreticular organs early after infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283678     DOI: 10.1038/86567

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  105 in total

1.  Peripheral prion pursuit.

Authors:  A Aguzzi
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

3.  Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice.

Authors:  Winston L Hutchinson; Jeff Herbert; Marina Botto; Mark B Pepys
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

Review 4.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

5.  Architecture of secondary lymphoid tissue in sheep experimentally challenged with scrapie.

Authors:  Marie L Davies; Lee J Hopkins; Sue Halliday; Fiona Houston; Nora Hunter; Ian McConnell
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

Review 6.  The immunology of neurodegeneration.

Authors:  Eva Czirr; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

7.  Complement protein C1q forms a complex with cytotoxic prion protein oligomers.

Authors:  Paul Erlich; Chantal Dumestre-Pérard; Wai Li Ling; Catherine Lemaire-Vieille; Guy Schoehn; Gérard J Arlaud; Nicole M Thielens; Jean Gagnon; Jean-Yves Cesbron
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

8.  Crystal structure of zebrafish complement 1qA globular domain.

Authors:  Hongyu Yuan; Rong Chen; Mansoor Tariq; Yanjie Liu; Yaping Sun; Chun Xia
Journal:  Protein Sci       Date:  2016-09-13       Impact factor: 6.725

Review 9.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

10.  Bacterial colitis increases susceptibility to oral prion disease.

Authors:  Christina J Sigurdson; Mathias Heikenwalder; Giuseppe Manco; Manja Barthel; Petra Schwarz; Bärbel Stecher; Nike J Krautler; Wolf-Dietrich Hardt; Burkhardt Seifert; Andrew J S MacPherson; Irène Corthesy; Adriano Aguzzi
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.